[1] |
World Health Organization . WHO global tuberculosis report 2017. Geneva:World Health Organization, 2017.
|
[2] |
Day JH, Grant AD, Fielding KL , et al. Does tuberculosis increase HIV load? J Infect Dis, 2004,190(9):1677-1684.
doi: 10.1086/424851
URL
pmid: 15478075
|
[3] |
López-Gatell H, Cole SR, Margolick JB , et al. Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. AIDS, 2008,22(14):1869-1873.
doi: 10.1097/QAD.0b013e32830e010c
URL
pmid: 3079345
|
[4] |
沈银忠, 卢洪洲 . 艾滋病合并结核病诊治现状. 中国实用内科杂志, 2015,35(8):671-674.
|
[5] |
邓国防, 周泱 . 浅谈HIV感染并发结核病患者的诊治问题. 结核病与肺部健康杂志, 2017,6(1):16-20.
doi: 10.3969/j.issn.2095-3755.2017.01.005
URL
|
[6] |
中华人民共和国卫生部. WS 293—2008艾滋病和艾滋病病毒感染诊断标准.北京: 中国标准出版社, 2008.
|
[7] |
中华人民共和国卫生部. WS 288—2008 肺结核诊断标准.北京: 人民卫生出版社, 2008.
|
[8] |
赵雁林, 王黎霞, 成诗明 , 等. 分枝杆菌分离培养标准化操作程序及质量保证手册.北京: 人民卫生出版社, 2013: 15-16
|
[9] |
Turetz ML, Ma KC . Diagnosis and management of latent tuberculosis. Curr Opin Infect Dis, 2016,29(2):205-211.
doi: 10.1097/QCO.0000000000000253
URL
pmid: 26836374
|
[10] |
Kaplan JE, Benson C, Holmes KK , et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep, 2009,58(RR-4):1-207.
URL
pmid: 19357635
|
[11] |
高孟秋 . γ-干扰素释放试验检测结果的临床意义解读. 中华结核和呼吸杂志, 2014,37(10):742-743.
doi: 10.3760/cma.j.issn.1001-0939.2014.10.010
URL
|
[12] |
李锋, 卢水华 . γ干扰素释放试验在儿童结核病和潜伏结核感染中的诊断价值. 中国防痨杂志, 2015,37(7):732-735.
doi: 10.3969/j.issn.1000-6621.2015.07.004
URL
|
[13] |
李晋, 杨倩婷, 岳建荣 , 等. γ干扰素释放试验与结核菌素皮肤试验在肺结核患者密切接触者随访中的应用比较. 中国防痨杂志, 2015,37(7):748-752.
doi: 10.3969/j.issn.1000-6621.2015.07.007
URL
|
[14] |
中华医学会结核病学分会. γ-干扰素释放试验在中国应用的建议. 中华结核和呼吸杂志, 2014,37(10):744-747.
doi: 10.3760/cma.j.issn.1001-0939.2014.10.011
URL
|
[15] |
Dai Y, Feng Y, Xu R , et al. Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis, 2012,31(11):3127-3137.
doi: 10.1007/s10096-013-1834-8
URL
pmid: 22833244
|
[16] |
Menzies D, Pai M, Comstock G . Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med, 2007,146(5):340-354.
doi: 10.7326/0003-4819-147-9-200711060-00020
URL
pmid: 17975194
|
[17] |
Chen J, Sun J, Zhang R , et al. T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency. Aids Res Hum Retroviruses, 2011,27(3):289-294.
doi: 10.1089/aid.2010.0062
URL
pmid: 20977360
|
[18] |
Nahid P, Dorman SE, Alipanah N , et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis, 2016,63(7):e147-e195.
doi: 10.1093/cid/ciw376
URL
pmid: 27516382
|
[19] |
Talati NJ, Gonzalez-Diaz E, Mutemba C , et al. Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays. BMC Infect Dis, 2011,11:264.
doi: 10.1186/1471-2334-11-264
URL
pmid: 3198954
|
[20] |
Santin M, Casas S, Saumoy M , et al. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons. Diagn Microbiol Infect Dis, 2011,69(1):59-65.
doi: 10.1016/j.diagmicrobio.2010.09.005
URL
|
[21] |
Danel C, Kabran M, Inwoley A , et al. Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d’Ivoire, West Africa. PLoS One, 2014,9(10):e107245.
doi: 10.1371/journal.pone.0107245
URL
pmid: 4199568
|
[22] |
Matsumoto T, Yamazaki T . The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT. Kekkaku, 2014,89(9):743-755.
URL
pmid: 25730946
|
[23] |
尹青琴, 申阿东 . 不同国家γ干扰素释放试验临床应用指南的概述. 国际呼吸杂志, 2011,31(21):1663-1666.
doi: 10.3760/cma.j.issn.1673-436X.2011.021.016
URL
|
[24] |
刘旭晖, 肖和平 . γ-干扰素释放试验(IGRA)对于诊断结核分枝杆菌感染的应用. 临床肺科杂志, 2009,14(5):672-674.
doi: 10.3969/j.issn.1009-6663.2009.05.062
URL
|
[25] |
Markowitz N, Hansen NI, Hopewell PC , et al. Incidence of Tuberculosis in the United States among HIV-Infected Persons. Annals of Internal Medicine, 1997,126(2):123.
doi: 10.7326/0003-4819-126-2-199701150-00005
URL
|
[26] |
Person AK, Pettit AC, Sterling TR . Diagnosis and treatment of latent tuberculosis infection: an update. Curr Respir Care Rep, 2013,2(4):199-207.
doi: 10.1007/s13665-013-0064-y
URL
pmid: 25298921
|
[27] |
van Zyl-Smit RN, Lehloenya RJ, Meldau R , et al. Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.( ®)TB and QFT-GIT). J Thorac Dis, 2016,8(3):482-489.
doi: 10.21037/jtd.2016.02.65
URL
pmid: 27076944
|
[28] |
Azghay M, Bouchaud O, Mechaï F , et al. Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis. Int J Infect Dis, 2016,44:25-30.
doi: 10.1016/j.ijid.2016.01.004
URL
pmid: 26780268
|
[29] |
邹晓艳, 杨德远, 孔昌盛 . 肺结核病患者痰标本性状及采样时间与抗酸杆菌阳性结果分析. 检验医学与临床, 2013,10(3):339-341.
doi: 10.3969/j.issn.1672-9455.2013.03.048
URL
|